Insider ownership feed
Showing Forms 3/4/5 accepted since 05 Jun 2026. Each row keeps issuer, reporting owner, reported value, role, and SEC evidence together.
Recent insider signals
Use the card actions for issuer context, owner profile, and SEC evidence.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Open the filing, then compare the reporting owner with issuer-level insider activity and related ownership pages.
Form 4 insider conviction
Role, issuer, transaction value, repeat activity, and SEC evidence.
Fresh reports
17,935
Forms 3, 4, and 5 filed in the current review window.
Visible buy/sell mix
0/2
Positive/negative net value among the preview cards.
Visible net value
-$308,931
Directional preview only; verify transaction rows and footnotes.
Newest evidence
15 Jun 2026
Use recency to separate fresh activity from stale insider stories.
Signal checks
positive net value and transaction code
multiple insiders or repeated filings
director, officer, or 10% owner context
issuer facts, 13D/G stakes, and 13F holders
SEC-verifiable Form 4 path
Open the filing, then follow the insider, issuer, or related ownership context.
John Townsend filed Form 4/A - Amendment for Unicycive Therapeutics, Inc. (UNCY). Role/context: CFO. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Patrick R. Gruber filed Form 4 for Gevo, Inc. (GEVO). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Douglas Jermasek filed Form 4/A - Amendment for Unicycive Therapeutics, Inc. (UNCY). Role/context: EVP, Corporate Strategy. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Mohammad Hirmand filed Form 4 for Whitehawk Therapeutics, Inc. (WHWK). Role/context: Director. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Oluwagbemileke Yusuf Agiri filed Form 4 for Gevo, Inc. (GEVO). Role/context: CFO. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
Peng Lu filed Form 4 for Pharvaris N.V. (PHVS). Role/context: Chief Medical Officer. Verify transaction rows, codes, and footnotes before treating this as a conviction signal.
Create an account from this card and we will save this insider to your watchlist after sign-in or verification.
| Security | Issuer | Reporting owner / CIK | Reported value | Report date | Actions |
|---|---|---|---|---|---|
| UNCY | Unicycive Therapeutics, Inc. | John Townsend CIK 0001511906 | $0 | 14 May 2026 | |
| GEVO | Gevo, Inc. | Patrick R. Gruber CIK 0001511369 | -$220,856 | 12 Jun 2026 | |
| UNCY | Unicycive Therapeutics, Inc. | Douglas Jermasek CIK 0001955273 | $0 | 14 May 2026 | |
| WHWK | Whitehawk Therapeutics, Inc. | Mohammad Hirmand CIK 0001654482 | $0 | 12 Jun 2026 | |
| GEVO | Gevo, Inc. | Oluwagbemileke Yusuf Agiri CIK 0002071241 | -$88,075 | 12 Jun 2026 | |
| PHVS | Pharvaris N.V. | Peng Lu CIK 0001972159 | $0 | 11 Jun 2026 | |
| BRUN | Boost Run Inc. | B. Luke Weil CIK 0001543122 | $0 | 12 May 2026 | |
| AMWL | American Well Corp | Stephen J. Schlegel CIK 0001824183 | -$85,449 | 11 Jun 2026 | |
| WHWK | Whitehawk Therapeutics, Inc. | Neil Desai CIK 0001878692 | $0 | 12 Jun 2026 | |
| GEVO | Gevo, Inc. | Bowron Kimberly T. CIK 0001866673 | -$22,048 | 12 Jun 2026 | |
| NHI | NATIONAL HEALTH INVESTORS INC | Robert A. McCabe Jr. CIK 0001079428 | +$63,767 | 15 Jun 2026 | |
| WHWK | Whitehawk Therapeutics, Inc. | Caley Castelein CIK 0001355758 | $0 | 12 Jun 2026 | |
| GEVO | Gevo, Inc. | Davaajargal Gendenjamts CIK 0002045065 | -$6,118 | 12 Jun 2026 | |
| PFG | PRINCIPAL FINANCIAL GROUP INC | D. Strable Soethout CIK 0001278726 | $0 | 11 Jun 2026 | |
| GEVO | Gevo, Inc. | Andrew Shafer CIK 0001999254 | -$13,458 | 12 Jun 2026 | |
| PRI | Primerica, Inc. | Barbara A. Yastine CIK 0001506757 | $0 | 12 Jun 2026 | |
| GEVO | Gevo, Inc. | Christopher Michael Ryan CIK 0001512143 | -$50,161 | 12 Jun 2026 | |
| PLUS | EPLUS INC | Erica Steinacker Stoecker CIK 0002092546 | $0 | 14 Jun 2026 | |
| PRI | Primerica, Inc. | Donald R. Williams CIK 0001487159 | $0 | 12 Jun 2026 | |
| WHWK | Whitehawk Therapeutics, Inc. | Behzad Aghazadeh CIK 0001701815 | $0 | 12 Jun 2026 | |
| SCWO | 374Water Inc. | Brad Ian Meyers CIK 0002000149 | -$45,046 | 11 Jun 2026 | |
| GEVO | Gevo, Inc. | Paul D. Bloom CIK 0001854032 | -$50,151 | 12 Jun 2026 | |
| PBLS | Parabilis Medicines, Inc. | Alexis Borisy CIK 0001319446 | $0 | 11 Jun 2026 | |
| PRI | Primerica, Inc. | Cynthia N. Day CIK 0001278770 | $0 | 12 Jun 2026 | |
| PLUS | EPLUS INC | Darren S. Raiguel CIK 0001736723 | $0 | 14 Jun 2026 | |
| RCAT | Red Cat Holdings, Inc. | Paul Funk II CIK 0002027952 | -$1,897,822 | 11 Jun 2026 | |
| PRI | Primerica, Inc. | Amber Lynne Cottle CIK 0001926145 | $0 | 12 Jun 2026 | |
| FATE | FATE THERAPEUTICS INC | Redmile Group, LLC CIK 0001425738 | $0 | 12 Jun 2026 | |
| FATE | FATE THERAPEUTICS INC | Michael S. Lee CIK 0001748010 | $0 | 12 Jun 2026 | |
| HAS | HASBRO, INC. | Carla Vernon CIK 0001961856 | $0 | 11 Jun 2026 | |
| PLUS | EPLUS INC | Mark P. Marron CIK 0001240888 | $0 | 14 Jun 2026 | |
| TTWO | TAKE TWO INTERACTIVE SOFTWARE INC | Daniel P. Emerson CIK 0001623654 | -$950,515 | 15 Jun 2026 | |
| PRI | Primerica, Inc. | Joel M. Babbit CIK 0001527144 | $0 | 12 Jun 2026 | |
| TCBK | TRICO BANCSHARES / | Jason Todd Levingston CIK 0002137997 | $0 | 12 Jun 2026 | |
| YICC | Yorkville International Capital Corp. | Yorkville International Capital Sponsor, LLC CIK 0002137930 | $0 | 15 Jun 2026 | |
| HIMS | Hims & Hers Health, Inc. | David B. Wells CIK 0001507645 | $0 | 11 Jun 2026 | |
| TCBK | TRICO BANCSHARES / | Angela Tamara Rudd CIK 0002137710 | $0 | 12 Jun 2026 | |
| HIMS | Hims & Hers Health, Inc. | Kare Schultz CIK 0001724567 | $0 | 11 Jun 2026 | |
| TCBK | TRICO BANCSHARES / | Daniel K. Bailey CIK 0001403901 | $0 | 12 Jun 2026 | |
| HIMS | Hims & Hers Health, Inc. | Andrea G. Perez Garcia CIK 0001849976 | $0 | 11 Jun 2026 | |
| SKWD | Skyward Specialty Insurance Group, Inc. | Thomas N. Schmitt CIK 0001937316 | -$430,963 | 12 Jun 2026 | |
| TCBK | TRICO BANCSHARES / | Gregory A. Gehlmann CIK 0001329631 | $0 | 12 Jun 2026 | |
| HIMS | Hims & Hers Health, Inc. | Patrick Harrison Carroll CIK 0001839736 | $0 | 11 Jun 2026 | |
| YICC | Yorkville International Capital Corp. | Troy Rillo CIK 0002084871 | $0 | 15 Jun 2026 | |
| TCBK | TRICO BANCSHARES / | Craig B. Carney CIK 0001198502 | $0 | 12 Jun 2026 | |
| PLUS | EPLUS INC | Elaine D. Marion CIK 0001444430 | $0 | 14 Jun 2026 | |
| HIMS | Hims & Hers Health, Inc. | Deborah M. Autor CIK 0001884671 | $0 | 11 Jun 2026 | |
| TCBK | TRICO BANCSHARES / | Richard P. Smith CIK 0001198468 | $0 | 12 Jun 2026 | |
| HIMS | Hims & Hers Health, Inc. | Kofi Owusu Amoo-Gottfried CIK 0001838060 | $0 | 11 Jun 2026 | |
| TCBK | TRICO BANCSHARES / | Peter G. Wiese CIK 0001750749 | $0 | 12 Jun 2026 |